Relationships between lead biomarkers and diurnal salivary cortisol indices in pregnant women from Mexico City: A cross-sectional study

Environmental Health: A Global Access Science Source

Volumn 13, Issue 1, 2014, Pages

  Braun, Joseph M ^a   Wright, Rosalind J ^b   Just, Allan C ^c   Power, Melinda C ^c   Ortiz, Marcela Tamayo ^c   Schnaas, Lourdes ^d   Hu, Howard ^e   Wright, Robert O ^b   Tellez Rojo, Martha Maria ^f  

^a BROWN UNIVERSITY   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d INSTITUTO NACIONAL DE SALUD PÚBLICA   (Mexico)

^e UNIVERSITY OF TORONTO   (Canada)

^f INSTITUTO NACIONAL DE PERINATOLOGÍA   (Mexico)

Author keywords

Cortisol; Epidemiology; Lead; Pregnancy

Indexed keywords

HYDROCORTISONE; LEAD; BIOLOGICAL MARKER;

BIOMARKER; BLOOD; BONE; CHILD HEALTH; CONCENTRATION (COMPOSITION); CONFIDENCE INTERVAL; EPIDEMIOLOGY; LEAD; PREGNANCY; STEROID;

ADULT; ADVERSE OUTCOME; AREA UNDER THE CURVE; ARTICLE; AWAKENING RESPONSE; BONE LEVEL; CIRCADIAN RHYTHM; COHORT ANALYSIS; CROSS-SECTIONAL STUDY; DIURNAL SLOPE; ENVIRONMENTAL EXPOSURE; FEMALE; GESTATIONAL AGE; HEALTH STATUS; HUMAN; HUMAN EXPERIMENT; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; LEAD BLOOD LEVEL; MATERNAL BLOOD; MATERNAL EXPOSURE; MEXICO; NERVOUS SYSTEM PARAMETERS; PATELLA; PREGNANT WOMAN; PRIORITY JOURNAL; PUERPERIUM; SALIVA LEVEL; SECOND TRIMESTER PREGNANCY; TIBIA; ADOLESCENT; CHEMISTRY; CITY; PHYSIOLOGY; POLLUTANT; PREGNANCY; SALIVA; YOUNG ADULT;

FEDERAL DISTRICT [MEXICO]; MEXICO CITY; MEXICO [NORTH AMERICA];

ADOLESCENT; ADULT; BIOLOGICAL MARKERS; CIRCADIAN RHYTHM; CITIES; CROSS-SECTIONAL STUDIES; ENVIRONMENTAL POLLUTANTS; FEMALE; HUMANS; HYDROCORTISONE; LEAD; MEXICO; PATELLA; PREGNANCY; SALIVA; TIBIA; YOUNG ADULT;

EID: 84988689729     PISSN: None     EISSN: 1476069X     Source Type: Journal    
DOI: 10.1186/1476-069X-13-50     Document Type: Article

References (39)

1. Nelson CA, Carver LJ: The effects of stress and trauma on brain and memory: A view from developmental cognitive neuroscience. Dev Psychopathol 1998, 10(4):793-809.
2. Sousa N, Almeida OF: Corticosteroids: sculptors of the hippocampal formation. Rev Neurosci 2002, 13(1):59-84.
3. Adam EK, Kumari M: Assessing salivary cortisol in large-scale, epidemiological research. Psychoneuroendocrinology 2009, 34(10):1423-1436.
4. Matthews K, Schwartz J, Cohen S, Seeman T: Diurnal cortisol decline is related to coronary calcification: CARDIA study. Psychosom Med 2006, 68(5):657-661.
5. Rondo PH, Lemos JO, Pereira JA, Souza JM: The relationship between cortisol concentrations in pregnancy and systemic vascular resistance in childhood. Early Hum Dev 2010, 86(2):127-131.
6. Bolten MI, Wurmser H, Buske-Kirschbaum A, Papousek M, Pirke KM, Hellhammer D: Cortisol levels in pregnancy as a psychobiological predictor for birth weight. Arch Womens Ment Health 2011, 14(1):33-41.
7. LeWinn KZ, Stroud LR, Molnar BE, Ware JH, Koenen KC, Buka SL: Elevated maternal cortisol levels during pregnancy are associated with reduced childhood IQ. Int J Epidemiol 2009, 38(6):1700-1710.
8. Bromer C, Marsit CJ, Armstrong DA, Padbury JF, Lester B: Genetic and epigenetic variation of the glucocorticoid receptor (NR3C1) in placenta and infant neurobehavior. Dev Psychobiol 2013, 55(7):673-83.
9. Marsit CJ, Maccani MA, Padbury JF, Lester BM: Placental 11-beta hydroxysteroid dehydrogenase methylation is associated with newborn growth and a measure of neurobehavioral outcome. PLoS One 2012, 7(3):e33794.
10. Hu H, Tellez-Rojo MM, Bellinger D, Smith D, Ettinger AS, Lamadrid-Figueroa H, Schwartz J, Schnaas L, Mercado-Garcia A, Hernandez-Avila M: Fetal lead exposure at each stage of pregnancy as a predictor of infant mental development. Environ Health Perspect 2006, 114(11):1730-1735.
11. Eubig PA, Aguiar A, Schantz SL: Lead and PCBs as risk factors for attention deficit/hyperactivity disorder. Environ Health Perspect 2010, 118(12):1654-1667.
12. Gump BB, Stewart P, Reihman J, Lonky E, Darvill T, Parsons PJ, Granger DA: Low-level prenatal and postnatal blood lead exposure and adrenocortical responses to acute stress in children. Environ Health Perspect 2008, 116(2):249-255.
13. Fortin MC, Cory-Slechta DA, Ohman-Strickland P, Nwankwo C, Yanger TS, Todd AC, Moynihan J, Walton J, Brooks A, Fiedler N: Increased lead biomarker levels are associated with changes in hormonal response to stress in occupationally exposed male participants. Environ Health Perspect 2012, 120(2):278-283.
14. Nieto-Fernandez FE, Ruiz A, Ntukogu N, Nodimelle L, Pryor SC: Short term lead exposure induces a stress-like response in adult mice. Med Sci Monit 2006, 12(10):BR325-329.
15. Rossi-George A, Virgolini MB, Weston D, Thiruchelvam M, Cory-Slechta DA: Interactions of lifetime lead exposure and stress: behavioral, neurochemical and HPA axis effects. Neurotoxicology 2011, 32(1):83-99.
16. Cory-Slechta DA, Virgolini MB, Thiruchelvam M, Weston DD, Bauter MR: Maternal stress modulates the effects of developmental lead exposure. Environ Health Perspect 2004, 112(6):717-730.
17. Miller DT, Paschal DC, Gunter EW, Stroud PE, D'Angelo J: Determination of lead in blood using electrothermal atomisation atomic absorption spectrometry with a L'vov platform and matrix modifier. Analyst 1987, 112(12):1701-1704.
18. Hu H, Milder FL, Burger DE: The use of K X-ray fluorescence for measuring lead burden in epidemiological studies: high and low lead burdens and measurement uncertainty. Environ Health Perspect 1991, 94:107-110.
19. Hu H, Rabinowitz M, Smith D: Bone lead as a biological marker in epidemiologic studies of chronic toxicity: conceptual paradigms. Environ Health Perspect 1998, 106(1):1-8.
20. Kim R, Aro A, Rotnitzky A, Amarasiriwardena C, Hu H: K x-ray fluorescence measurements of bone lead concentration: The analysis of low-level data. Phys Med Biol 1995, 40(9):1475-1485.
21. Cole SR: Chu H, Nie L. Estimating the odds ratio when exposure has a limit of detection. International journal of epidemiology: Schisterman EF; 2009.
22. Chuang HY, Schwartz J, Gonzales-Cossio T, Lugo MC, Palazuelos E, Aro A, Hu H, Hernandez-Avila M: Interrelations of lead levels in bone, venous blood, and umbilical cord blood with exogenous lead exposure through maternal plasma lead in peripartum women. Environ Health Perspect 2001, 109(5):527-532.
23. Bouchard MF, Bellinger DC, Weuve J, Matthews-Bellinger J, Gilman SE, Wright RO, Schwartz J, Weisskopf MG: Blood lead levels and major depressive disorder, panic disorder, and generalized anxiety disorder in US young adults. Arch Gen Psychiatry 2009, 66(12):1313-1319.
24. Berry CA, Quinn KA, Portillo N, Shalowitz MU: Reliability and validity of the Spanish Version of the Crisis in Family Systems-Revised. Psychol Rep 2006, 98(1):123-132.
25. Cox JL, Holden JM, Sagovsky R: Detection of postnatal depression. Development of the 10-item Edinburgh Postnatal Depression Scale. Br J Psychiatry 1987, 150:782-786.
26. Fitzmaurice GM, Laird NM, Ware JH: Applied Longitudinal Data Analysis. 2nd edition. Hoboken: Wiley; 2004.
27. Harrell FE: Regression Modeling Strategies. New York: Springer-Verlag; 2001.
28. DeSantis AS, Adam EK, Mendelsohn KA, Doane LD: Concordance between self-reported and objective wakeup times in ambulatory salivary cortisol research. Int J Behav Med 2010, 17(1):74-78.
29. Braun JM, Hoffman E, Schwartz J, Sanchez B, Schnaas L, Mercado-Garcia A, Solano-Gonzalez M, Bellinger DC, Lanphear BP, Hu H, Tellez-Rojo MM, Wright RO, Hernandez-Avila M: Assessing windows of susceptibility to lead-induced cognitive deficits in Mexican children. Neurotoxicology 2012, 33(5):1040-1047.
30. Warriner AH, Saag KG: Glucocorticoid-related bone changes from endogenous or exogenous glucocorticoids. Curr Opin Endocrinol Diabetes Obes 2013, 20(6):510-516.
31. Janakiraman V, Ettinger A, Mercado-Garcia A, Hu H, Hernandez-Avila M: Calcium supplements and bone resorption in pregnancy: A randomized crossover trial. Am J Prev Med 2003, 24(3):260-264.
32. Tellez-Rojo MM, Hernandez-Avila M, Lamadrid-Figueroa H, Smith D, Hernandez-Cadena L, Mercado A, Aro A, Schwartz J, Hu H: Impact of bone lead and bone resorption on plasma and whole blood lead levels during pregnancy. Am J Epidemiol 2004, 160(7):668-678.
33. Rice D, Barone S Jr: Critical periods of vulnerability for the developing nervous system: evidence from humans and animal models. Environ Health Perspect 2000, 108(Suppl 3):511-533.
34. Beydoun H, Saftlas AF: Physical and mental health outcomes of prenatal maternal stress in human and animal studies: A review of recent evidence. Paediatr Perinat Epidemiol 2008, 22(5):438-466.
35. Bellinger DC: Lead. Pediatrics 2004, 113(4 Suppl):1016-1022.
36. Lidsky TI, Schneider JS: Lead neurotoxicity in children: basic mechanisms and clinical correlates. Brain 2003, 126(Pt 1):5-19.
37. Fries E, Dettenborn L, Kirschbaum C: The cortisol awakening response (CAR): facts and future directions. Int J Psychophysiol 2009, 72(1):67-73.
38. Halpern CT, Whitsel EA, Wagner B, Harris KM: Challenges of measuring diurnal cortisol concentrations in a large population-based field study. Psychoneuroendocrinology 2012, 37(4):499-508.
39. Suglia SF, Staudenmayer J, Cohen S, Enlow MB, Rich-Edwards JW, Wright RJ: Cumulative Stress and Cortisol Disruption among Black and Hispanic Pregnant Women in an Urban Cohort. Psychological trauma: Theory, research, practice and policy 2010, 2(4):326-334.